Erythromycin
Product Images NDC 75834-243

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 75834-243). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Erythromycin 01)

Chemical structure of erythromycin showing its complex macrolide ring system with attached sugar moieties, including a desosamine sugar and cladinose sugar, as depicted in a black-and-white line diagram.*

FDA Label Image

Principal Display Panel (250 mg Tablet Bottle Label)

Label for Erythromycin Tablets, USP, 250 mg, containing 100 tablets, manufactured by Nivagen Pharmaceuticals, Inc. The label includes storage instructions, dosing information, and warnings. It also displays the NDC number 75834-242-01 and mentions manufacturing by Cadila Pharmaceuticals Ltd.*

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Label for Erythromycin Tablets, USP, 500 mg, in a bottle containing 100 tablets. The label shows the NDC 75834-243-01, indicates the manufacturer as Nivagen Pharmaceuticals, Inc., Sacramento, CA, and mentions Cadila Pharmaceuticals Ltd. as the manufacturer. It includes storage instructions, dosage information, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.